Sermorelin Research Guide
5mg · Research compound — not for human consumption
Research Overview
Sermorelin is a synthetic 29-amino-acid peptide corresponding to the biologically active N-terminal fragment of growth-hormone-releasing hormone (GHRH). It has been studied as a research compound for its interaction with the pituitary GHRH receptor. This material is intended for laboratory research only and is not intended for human consumption.
Structural & Class Overview
A truncated GHRH analog comprising the first 29 amino acids of the native 44-amino-acid GHRH molecule; research established that this fragment retains GHRH-receptor biological activity. It is classified as a GHRH-receptor agonist acting through the Gs-protein/adenylate-cyclase/cAMP pathway. It was historically developed under the name Geref.
General Research Interest
Research interest includes GHRH-receptor binding and activation; cAMP-mediated signaling in somatotroph models; pulsatile growth-hormone release patterns; comparative structure-activity studies of GHRH fragments; and growth-hormone/IGF-I axis regulation in preclinical systems.
Storage Considerations
Store the lyophilized research peptide cool and dark, and protect from light, heat, and moisture. Reconstituted material is generally handled under refrigeration for laboratory use. For research handling only; not for human use.
Testing & Quality Considerations
Quality considerations for research material include HPLC purity assessment, mass-spectrometry identity confirmation, and verification against a batch Certificate of Analysis (COA).
References
- Sermorelin — Wikipedia
- Growth hormone secretagogues: history, mechanism of action, and clinical development (Wiley)
References are provided for scientific context. Linked sources are independent and not affiliated with iNGEN MD.
